How are botox and fillers in Korea dosed and priced?

Botox and fillers in Korea are sold by quantity rather than by procedure, which is the single fact that makes one clinic's quote comparable to another's. Botulinum toxin is measured in units and filler is measured in millilitres, and a price attached to a body part — "forehead", "under-eye", "chin" — leaves the quantity unstated. Two clinics can advertise the same area at prices that differ by a factor of three and both be quoting honestly, because one is describing a small touch-up and the other a full treatment. Korea runs an unusually large volume of injectable work and an unusually competitive market for it, and the result is a pricing landscape that rewards a visitor who asks two specific questions and penalises one who asks only about the total.

Why are botox and fillers in Korea quoted by quantity rather than by area?#

Injectables are quoted by quantity because the material itself is the cost, and the amount needed varies from face to face rather than from procedure to procedure. A laser session consumes a machine's time; an injectable session consumes a measurable volume of a prescription product that the clinic has purchased. That difference is why a laser price list can be read straight down the page while an injectable price list cannot.

The two product classes are counted differently, and conflating them is the most common source of confusion in a consultation. Botulinum toxin is a purified protein that temporarily reduces the contraction of the muscle it is placed in, and it is measured in units of biological activity. Dermal filler is a gel that occupies space under the skin, and it is measured by volume and sold in a sealed syringe. One softens movement; the other restores or adds contour. A clinic that quotes "one area" without saying how many units, or "lips" without saying how many millilitres, has given a number that cannot be compared with anything.

Skin boosters and micro-injection treatments deserve to be separated out from this group, because Korean clinic menus blur that line more than most. Hydrating injectables delivered broadly into the upper skin, and toxin diluted and placed very superficially across a wide area, sit in a different category from the contour work described here — the trade-offs specific to that group are covered in our guide to skin boosters in Korea.

What does a unit of botulinum toxin actually mean?#

A unit of botulinum toxin is a measure of biological potency defined by each manufacturer's own assay, which means units are specific to the product and are not interchangeable between brands. This is not a marketing distinction. Product labelling for botulinum toxin preparations states plainly that potency units are particular to each preparation and cannot be converted into the units of another, and clinicians treat the conversion between products as a clinical judgement rather than as arithmetic.

The practical consequence for a price comparison is direct: "50 units" means different quantities of biological activity depending on which product was drawn into the syringe, so a per-unit price only becomes meaningful once the product is named alongside it. A quote of a lower price per unit for a different product is not automatically a saving, and a quote of a higher one is not automatically a premium.

How many units are appropriate is a separate question, and it is not one an article can answer. Botulinum toxin is a prescription-only medicine in Korea as elsewhere, and the amount, the injection points, and the depth are determined by a licensed physician who has examined how a particular face moves. Muscle bulk, movement pattern, prior treatment history, and the outcome being aimed at all change the number. What a visitor can reasonably do is ask for the planned quantity and the product name to be written down before the injection, which turns an opaque quote into a record that can be compared and repeated.

Which botulinum toxin and filler brands are used in Korean clinics?#

Korean clinics work with a mix of imported originator products and domestically manufactured ones, and the domestic products are a substantial part of why prices sit where they do. Korea hosts several established botulinum toxin manufacturers whose products are licensed by the Ministry of Food and Drug Safety and used routinely in local practice, alongside the imported brands familiar to patients from North America and Europe.

Brand names are worth knowing not as a ranking but as a way of reading a quote. A clinic quoting a domestic toxin and a clinic quoting an imported one are selling different inputs at different acquisition costs, and neither is a concealed downgrade. Some Korean-made products also circulate internationally under different names — the toxin marketed in Korea as Nabota, made by Daewoong, is sold in the United States as Jeuveau — which is a useful reminder that the familiar name on a home-market menu is a commercial label rather than a statement about quality.

Within hyaluronic acid filler there is a further distinction that matters more than the brand on the box. Manufacturers produce multiple lines with different gel firmness, and firmer, more cohesive gels are used where structural support is wanted while softer ones are placed in mobile or thin-skinned areas. A quote that names only a brand has left out the line, and the line is what determines whether a product suits the area being treated.

How much do botox and fillers in Korea actually cost?#

Injectable costs in Korea sit well below equivalent private pricing in the United States, the United Kingdom, and Australia, with injection-based treatments commonly reported in a range of roughly $200 to $600 per treated area in 2026 and a broader cost differential of 30 to 60 per cent across aesthetic procedures. The gap is real, and it is the main reason injectables appear on so many medical travel itineraries. It is also easy to misread.

Four things move a quoted figure, and none of them is visible in an advertised headline price. Quantity is the largest: a per-area price covering a modest unit count is not comparable to one covering a full treatment of the same area. Which product is used is the second, since domestic and imported preparations sit at different acquisition costs. Value-added tax is the third — cosmetic procedures in Korea carry VAT, and menu prices are not consistently displayed inclusive of it, so a total can rise at the payment desk. Whether the price is a package or an event rate is the fourth, and packages that bundle several sessions or several areas complicate any per-unit comparison rather than simplifying it.

There is one more piece of arithmetic that a headline price never shows: how long the result lasts. Botulinum toxin effects typically fade over roughly three to four months, while hyaluronic acid fillers persist for something closer to six to eighteen months depending on the product, the placement, and the individual. A cheaper session repeated more often is not a saving, and comparing annual cost rather than session cost changes which option looks economical. The wider picture of how Korean aesthetic pricing compares with home-market pricing is set out in our Korea versus US treatment cost comparison.

What should you settle before an injectable appointment in Korea?#

The questions worth asking before an injectable appointment concern reversibility, complications, and timing rather than price, because those are the variables that are difficult to fix from another country. Injectables differ from most aesthetic procedures in one important way: some of them can be partially undone, and some of them cannot, and knowing which category you are in before the syringe is opened changes how much risk a decision carries.

Hyaluronic acid filler can be broken down by hyaluronidase, an enzyme that dissolves the gel, which makes it the most correctable of the injectable categories when placement or volume is unsatisfactory. Collagen-stimulating products based on poly-L-lactic acid or calcium hydroxylapatite have no equivalent reversal agent and resolve only with time. Botulinum toxin has no antidote either, but its effect is inherently temporary and fades on its own. That hierarchy is worth holding in mind when a clinic proposes a material for a first-time treatment far from home.

Complications deserve a plain statement rather than a euphemism. The serious adverse event associated with dermal filler is vascular occlusion, in which material enters or compresses a blood vessel and interrupts blood supply to the tissue it feeds; skin damage and, in rare cases involving vessels around the eye, vision loss have been documented in the medical literature. It is uncommon, and it is the reason injectable work belongs with a licensed physician who knows facial vascular anatomy and keeps hyaluronidase on the premises. Asking whether the clinic stocks it, and who at the clinic manages a complication if one occurs, is a reasonable question rather than an awkward one.

✨ In short#

Botox and fillers in Korea become comparable the moment a quote states a quantity and a product name, and stay incomparable for as long as it states only an area and a total. Toxin units are defined per product and do not convert between brands; filler is sold by the syringe and differs by gel line as much as by brand. The cost advantage over private pricing in the United States, the United Kingdom, and Australia is genuine, but it is measured properly only against quantity, tax, and how long the result lasts. The decisions that matter most — how much, where, and with what — belong to a licensed physician who has examined your face, and the most useful thing a visitor brings to the consultation is a written record of what was agreed.